Share chart DA32 Life Science Tech Acquisition Corp.
Extended chart
Simple chart
About DA32 Life Science Tech Acquisition Corp.
DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.IPO date | 2021-07-28 |
---|---|
ISIN | US23312M1062 |
Industry | Capital Markets |
Sector | Financials |
Валюта | usd |
Валюта отчета | usd |
Цена ао | 10.32 |
Change price per day: | 0% (10.32) |
---|---|
Change price per week: | 0% (10.32) |
Change price per month: | 0% (10.32) |
Change price per 3 month: | 0% (10.32) |
Change price per half year: | 0% (10.32) |
Change price per year: | 0% (10.32) |
Change price per 3 year: | +6.61% (9.68) |
Change price per year to date: | 0% (10.32) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
First Trust Capital Management L.P. | 2355502 | 11.41 |
Deerfield Management Company, L.P. (Series C) | 1600000 | 7.75 |
Blackrock Inc. | 1500000 | 7.26 |
Saba Capital Management, L.P. | 1258277 | 6.09 |
Periscope Capital Inc. | 1109802 | 5.37 |
Magnetar Financial LLC | 913739 | 4.42 |
Millennium Management LLC | 754100 | 3.65 |
Moore Capital Management, LP | 750000 | 3.63 |
Citadel Advisors Llc | 727322 | 3.52 |
Janus Henderson Group PLC | 430000 | 2.08 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Steven Kafka Ph.D. | CEO & Director | 1969 (56 years) | |
Mr. Christopher E. Wolfe | CFO & Sec. | 1980 (45 years) |